Former CNET editor Dong Ngo has been involved with technology since 2000, starting with testing gadgets and writing code for CNET Labs' benchmarks. He managed CNET's San Francisco Labs, reviews 3D ...
On Track to Commence Pivotal Confirmatory Head and Neck Cancer Registration Study by Summer/Fall 2026Signed Key Partnership with Amarox to Advance Multikine Approval and Commercialization in Saudi ...
VIENNA, Va., December 29, 2025--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) reported financial results for the fiscal year ended September 30, 2025, as well as key clinical and corporate ...
CEL-SCI Corporation OverviewBiotechnology / Healthcare CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using ...
Multikine sales in Saudi Arabia upon receipt of Breakthrough Medicine Designation Amarox to act as the local regulatory representative and lead all communications with the Saudi Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results